Voyager Therapeutics VYGR
NASDAQ VYGR
$2.61 -0.07 (-2.62%)
As of: Oct 2, 2026 · 10:49 AM EDT

Voyager Therapeutics (VYGR) Non-Current Deffered Revenue (2015 - 2025)

Updated

Voyager Therapeutics (VYGR) posted Non-Current Deffered Revenue of $1.47 million for Q3 2025, down 87.9% from $12.15 million a year earlier and down 43.6% from the prior quarter.

Analysis

Voyager Therapeutics (VYGR) Non-Current Deffered Revenue (2015 - 2025) Analysis & Trends

At the end of FY2024, Voyager Therapeutics' Non-Current Deffered Revenue came in at $6 million, down 81.4% from FY2023.

  • Annual Non-Current Deffered Revenue shows a five-year compound annual growth rate of -47.3% (FY2019 to FY2024).
  • In prior years, Voyager Therapeutics' Non-Current Deffered Revenue was $32.36 million in FY2023 (+401.7%), $6.45 million in FY2022 (-21.4%), $8.21 million in FY2021 (-77.3%) and $36.09 million in FY2020 (-75.5%).
  • The Q3 2025 figure stands as the lowest quarterly Non-Current Deffered Revenue in data going back to Q3 2015.
  • On a year-over-year basis, Non-Current Deffered Revenue has declined in each of the last seven quarters, with an average decline of 16.4% over the last eight quarters.
  • The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was Q1 2023, with growth of 833.5%; the weakest was Q3 2025, with a decline of 87.9%.
  • According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $2.61 million (Q2 2025), $4.76 million (Q1 2025) and $6 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Voyager Therapeutics 164.21 Mn -498.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1.47 Mn
Jun 30, 2025 2.61 Mn
Mar 31, 2025 4.76 Mn
Dec 31, 2024 6.00 Mn
Sep 30, 2024 12.15 Mn
Jun 30, 2024 19.47 Mn
Mar 31, 2024 13.16 Mn
Dec 31, 2023 32.36 Mn
Sep 30, 2023 37.83 Mn
Jun 30, 2023 51.38 Mn
Mar 31, 2023 78.87 Mn
Dec 31, 2022 6.45 Mn
Sep 30, 2022 7.39 Mn
Jun 30, 2022 7.88 Mn
Mar 31, 2022 8.45 Mn
Dec 31, 2021 8.21 Mn
Sep 30, 2021 29.64 Mn
Jun 30, 2021 31.66 Mn
Mar 31, 2021 33.61 Mn
Dec 31, 2020 36.09 Mn
API Access

Voyager Therapeutics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VYGR&period=max&api_key=YOUR_API_KEY